Stay updated on PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page.

Latest updates to the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 from the history. This updates the page's version history to reflect the latest revision of the study record.SummaryDifference0.1%

- Check10 days agoChange DetectedA new revision entry (v3.4.1) was added to the history and the previous revision (v3.4.0) was removed.SummaryDifference0.1%

- Check17 days agoChange DetectedThe history view now includes a glossary option, color-coded additions and deletions, and an updated revision label (v3.4.0). There are no changes to core study data or primary content; the updates are cosmetic/UI and metadata only.SummaryDifference0.8%

- Check32 days agoChange DetectedThe record history shows a new revision label (v3.3.4) added and the previous revision (v3.3.3) removed; no study data, content, or page functionality appear to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedThe history shows an addition of Revision: v3.3.3 and deletions including HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedRevision history shows Revision: v3.3.2 added and Revision: v3.2.0 removed, indicating a background software update rather than changes to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page.